Business News
AstraZeneca says Imfinzi combo shows promise in late-stage lung cancer trial By Reuters
[ad_1]
© Reuters. FILE PHOTO: The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, US, March 22, 2021. REUTERS / Rachel Wisniewski / File Photo
(Reuters) – Drugmaker AstraZeneca (NASDAQ 🙂 said on Thursday its cancer drug Imfinzi, when given along with neoadjuvant chemotherapy in a late-stage trial, showed promise in helping patients with an aggressive form of lung cancer before surgery.
The combination showed a statistically significant and significant improvement in pathologic complete response compared with neoadjuvant chemotherapy alone in patients with resectable non-small cell lung cancer, the company said.
[ad_2]
Source link